SunHo Announces First Patient Dosed in Phase 1/2 Clinical Tr

/PRNewswire/ -- SunHo BioPharmaceutical Co., Ltd. ("SunHo"), a clinical-stage leading biopharma in immunocytokines with full-set of capabilities from discovery...

Related Keywords

China , Sunho , Heilongjiang , Nanjing , Jiangsu , Liusong , Shaanxi , , China Biopharmaceutical Co Ltd , European Medicines Agency , Drug Administration , Sunho Biopharmaceutical Co Ltd , China National Medicinal Products Administration , Liusong Yin , Executive President , Chief Science Officer , Armed Immunocytokine , Armed Immunocytokine Platform , Armed Innate Effector Multispecific Platform , Antibody Platform , National Medicinal Products Administration , Sunho China Biopharmaceutical Co , Td , Biotechnology , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Clinical Trials Amp Medical Discoveries ,